Global Good Impact Interview with our CEO

Can you introduce yourself and tell us about your role?

I’m Scott, the founder of Sensore. We are developing a smart fabric pressure-sensing solution designed to continuously monitor pressure and identify risks early, allowing pressure ulcers to be prevented before they develop.

I founded the company during my third year of PhD studies in Materials Science at the University of Manchester. Since then, I’ve been focused on understanding the true scale of pressure ulcers in the UK and developing technology that supports better prevention for people at risk, their families, and the professionals who care for them.

How did your company come about, and what was the motivation behind it?

Sensore was founded out of a clear frustration: pressure ulcers remain widespread, costly, and devastating, despite being largely preventable. Prevention still relies heavily on manual processes and intermittent checks, placing significant strain on patients, families, and already overstretched care teams.

With a background in materials science, printed electronics, and smart textiles, I could see that the technology existed to do better. Sensore was created to translate advanced research into something practical, comfortable, and scalable — a solution that can monitor pressure in real time and support prevention before harm occurs.

At its core, the company exists to shift pressure care from a reactive model to a proactive one. The ambition is systemic change: making high-quality pressure ulcer prevention accessible across hospitals, care homes, and people’s own homes, and ensuring avoidable harm is identified early rather than treated late.

Can you describe your company’s mission and values?

Our mission is to eradicate pressure ulcers by making preventive technology smarter, more accessible, and more comfortable for everyone who needs it. Sensore is being developed to reliably monitor pressure, flag emerging risk patterns, and support timely offloading and repositioning. The goal is to enable better care decisions and greater independence across home, community, and clinical settings.

Our values are built around four pillars:

• Innovation with Impact: applying advanced materials and sensing to deliver measurable improvements in people’s lives.

• User-Centric Design: co-designing with end users and frontline professionals to ensure the solution fits real-world needs.

• Integrity and Trust: committing to rigorous validation, transparency, strong data privacy, and ethical use of AI.

• Empowerment: giving people at risk, and those who support them, clearer feedback and greater control to prevent harm.

What are some of the most pressing social issues that your company is working to address through its technology?

Pressure ulcers sit at the intersection of avoidable harm, workforce strain, and inequality in access to high-quality prevention. In the UK, estimates suggest over 700,000 people (Wood, J. et al. 2019) develop a pressure ulcer each year, with treatment costs cited at around £2.6 billion annually. Guidance and research also indicate that a large proportion are preventable with effective monitoring and timely pressure relief.

Sensore is tackling this by widening access to data-driven prevention. By standardising prevention across settings – from hospitals to care homes to people’s own homes – we aim to reduce avoidable harm, support stretched health and social care teams, and help close gaps in care quality. More broadly, it is part of the shift from reactive treatment to proactive, preventative care.

How does your company measure the impact of its work in creating positive change?

We measure impact across three levels:

1. Usability and adoption: prevention only works if people use it. We assess comfort, intrusiveness, and ease of use using established tools such as the System Usability Scale, alongside workload measures and real engagement data, including how often users respond to prompts or adjust posture based on live feedback.

2. Behavioural and clinical indicators: in the short term, we track reductions in sustained high-pressure events and improvements in timely offloading. Over time, we focus on reductions in ulcer incidence and severity, alongside reported improvements in comfort, confidence, and quality of life.

Service impact and economics: we model effects on staff time, length of stay, and overall cost of care, using real-world data to understand how prevention changes workflows and where investment delivers value.

In your opinion, what impact will technology have in creating a better future?

In healthcare, technology’s greatest value often lies in earlier prevention rather than dramatic intervention. Many harms become costly crises because they are only identified after the fact. Low-friction, continuous sensing can shift care from periodic checks to timely, individualised action.

For pressure ulcers, current practice relies heavily on intermittent assessment and routine repositioning. Continuous pressure monitoring enables a different approach: identifying risk as it emerges and guiding pressure relief in the moment. This doesn’t replace clinical judgement — it makes risk visible between clinical touchpoints, including in home and social care settings.

What advice do you have for other companies looking to use tech for good and positively impact the world?

Start by defining the human problem in operational terms: who is being harmed, where it happens, how often, and which decisions need to change to reduce that harm. If you can’t clearly describe the workflow and constraints, you’ll likely build something impressive that ends up unused. Design with users and frontline professionals from the start, especially groups that are often underrepresented. Inclusion improves safety, usability, and real-world relevance.

Finally, treat evidence, regulation, and data governance as core product features. In healthcare, impact is demonstrated through usability, safety, and outcomes, not slogans. Define success criteria early, plan studies early, and align incentives with improved results — not just deployment. Measure impact honestly, iterate transparently, and choose partners who care about outcomes as much as adoption.